Kiriminjeswara research (IMAGE)
Caption
Researchers used an artificial intelligence platform to create a T-cell-based COVID-19 vaccine that may last longer than the current vaccines.
Credit
Girish Kirimanjeswara, Penn State
Usage Restrictions
Educational use only
License
Original content